IgG serum antibody was measured by ELISA in patients with Crohn's disease (15), ulcerative colitis (15), and in normal controls (15) to 12 strains ofSaccharomyces cerevisiae (baker's and brewer's yeast) and to the two major serotypes of the commensal yeast Candida albicans. Antibody to 11 of the 12 strains of S cerevisiae was raised in patients with Crohn's disease but not in patients with ulcerative colitis when compared with controls (p<0001). The pattern of antibody response to these 11 strains was variable, however, suggesting the likelihood of antigenic heterogeneity within the species. Antibody to C albicans was not significantly different in patient and control groups. The specificity of this unusual antibody response in Crohn's disease for S cerevisiae suggests that it is not simply the result of a generalised increase in intestinal permeability. Furthermore, because brewing and baking strains detected the response, the relevant antigen(s) are presumably common in the diet. Hypersensitivity to dietary antigens may be involved in the pathogenesis of Crohn's disease, and the role of S cerevisiae requires further investigation.
We have previously found raised levels of antibody to a strain of baker's yeast (Saccharomyces cerevisiae) in patients with Crohn's disease but not in patients with ulcerative colitis when compared with normal controls.' It is possible that this unusual antibody in Crohn's disease is part of a pathological response to an organism which is involved in the preparation of many components of a typical Western diet. The possibility that hypersensitivity to dietary antigens may contribute to the pathogenesis of Crohn's disease has often been considered and antibody to several food antigens has been studied without providing evidence of a specific abnormality in Crohn's disease. 25 The aim of the present study was to establish whether our initial findings of raised levels of antibody to a single strain of S cerevisiae in Crohn's disease could be extended to .%f%II %% f-% patterns are shown for S cerevisiae NCYC 1108 and C albicans NCPC 3153 (Fig 1) . Although patients with Crohn's disease had raised levels of antibody to all S cerevisiae strains other than NCYC 679, however, the pattern of reactivity of patients to these strains was variable. An example comparison of antibody results for each patient to S cerevisiae ale strain NCYC 1108 and lager strain NCYC 1324 is shown in Figure 2 . 
